You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DESOGESTREL; ETHINYL ESTRADIOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for desogestrel; ethinyl estradiol and what is the scope of patent protection?

Desogestrel; ethinyl estradiol is the generic ingredient in seventeen branded drugs marketed by Organon Usa Inc, Duramed Pharms Barr, Janssen Pharms, Lupin Ltd, Aspen Global Inc, Dr Reddys Labs Sa, Naari Pte Ltd, Novast Labs, Watson Labs, Xiromed, Endo Operations, Aurobindo Pharma, Barr, Teva Branded Pharm, and Glenmark Pharms Ltd, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

Sixteen suppliers are listed for this compound.

Summary for DESOGESTREL; ETHINYL ESTRADIOL
Recent Clinical Trials for DESOGESTREL; ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Andromaco S.A.Phase 1
National Institutes of Health (NIH)Phase 3
University of PennsylvaniaPhase 3

See all DESOGESTREL; ETHINYL ESTRADIOL clinical trials

US Patents and Regulatory Information for DESOGESTREL; ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Naari Pte Ltd DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 207067-001 Sep 13, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed VOLNEA desogestrel; ethinyl estradiol TABLET;ORAL-28 202689-001 Sep 9, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Ltd VIORELE desogestrel; ethinyl estradiol TABLET;ORAL-28 091346-001 Apr 2, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd ENSKYCE desogestrel; ethinyl estradiol TABLET;ORAL-28 201887-001 Mar 7, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed ISIBLOOM desogestrel; ethinyl estradiol TABLET;ORAL-28 202789-001 Aug 12, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DESOGESTREL; ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071-001 Dec 10, 1992 ⤷  Sign Up ⤷  Sign Up
Aspen Global Inc CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090-001 Dec 20, 2000 ⤷  Sign Up ⤷  Sign Up
Aspen Global Inc CYCLESSA desogestrel; ethinyl estradiol TABLET;ORAL-28 021090-001 Dec 20, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.